CVS Health Corporation vs Johnson & Johnson
CVS vs JNJ — side-by-side comparison from reported financials. CVS leads 5, JNJ leads 6 of 11 comparable metrics.
CVS Health Corporation
CVS · Healthcare
$86.44-1.55%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | CVS | JNJ |
|---|---|---|
| Price | $86.44 | $261.79 |
| Market cap | $111B | $631B |
| Revenue (TTM) | $415B | $97.9B |
| Revenue growth | +7.6% | +5.6% |
| Net margin | 1.2% | 21.5% |
| Free cash flow | $11.8B | $22.2B |
| Net cash (debt) | ($49.9B) | ($27.8B) |
| 1-year price return | +12.6% | +37.0% |
| P/E | 22.5 | 29.9 |
| P/E vs own history (cheap-side %) | 39% | 16% |
| Dividend yield | 3.10% | 2.00% |
| Return on equity | 6% | 26% |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 300,000 | 140,800 |
Full résumé-style profiles: CVS CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.